Since the possibility of asymptomatic infection with Borrelia burgdorferi has been suggested by a positive serology found in healthy subjects, we hypothesized that these subjects might excrete borrelial DNA sequences in urine as happens in patients with Lyme borreliosis. We found borrelial sequences by nested PCR in the urine samples from 3 of 13 healthy B. burgdorferi antibody-positive adults but not in urine samples from 79 antibody-negative healthy controls. After therapy with doxycycline, the urine samples were repeatedly negative for B. burgdorferi DNA. We conclude that urinary excretion of borrelial DNA sequences may occur in seropositive healthy subjects during asymptomatic infection. Demonstration of such sequences in urine must be interpreted cautiously and may not necessarily prove a borrelial cause of disease.
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Borrelia burgdorfeen is the causative agent of Lyme borreliosis, a tick-borne disease with a broad array of clinical manifestations including erythema migrans, lymphocytic meningoradiculoneuritis, carditis, arthritis, encephalopathy, and acrodermatitis chronica atrophicans in adults and children (1, 17) . Laboratory confirmation of infection with B. burgdorferi is usually obtained by serological methods (1, 17) . In addition, isolation of the organism from body fluids or demonstration of specific DNA by PCR in patients with Lyme borreliosis has been used and considered to be more specific than serology (4, 5, 7, 10, 11, 14, 15) . In contrast to serology, which might indicate immune memory of past events, direct demonstration of the organism in patient material is considered to be indicative of active infection. Even several years after the onset of symptoms, B. burgdorferi could be demonstrated by these methods in patients with Lyme borreliosis, thus showing the remarkable capacity of the organism to maintain a persistent infection (7, 10, (13) (14) (15) (8) . Specific detection of B. burgdorferi DNA was performed by nested PCR with primers from the fla gene as described previously (7, 10) . The extraction of DNA and the PCR conditions were as described previously (7). The PCR assay amplifies a portion of the flagellin gene highly specific for B. burgdorfeni (7, 10) . The specificity of the assay was shown by the failure to amplify DNA from various bacterial species (7, 10) . Several controls were included in the PCR experiments. All amplifications were performed in parallel with a negative control (autoclaved water) to exclude spurious results due to trace contamination. In order to exclude inhibitory effects, urine samples were mixed with 100 B. burgdorferi B 31 cells and extracted as described previously (7, 10) . The precautions used to prevent contaminations were those described by Kwok and Higuchi (12) . To further confirm the identity of the DNA resulting from the fla PCR, these fragments were purified by the Prep-A-Gene purification kit, as described by the manufacturer (Bio-Rad, Munich, Germany). A total of 1 ,ig of the DNA was subjected to Taq-cycle sequencing reactions with the Prism Ready Reaction DyeDeoxy Terminator Cycle Sequencing kit (Applied Biosystems, Darmstadt, Germany). A total of 9.5 pul of terminator premix, template DNA (1 jig), and 3.2 pmol of the primers previously described (10) were mixed in a 0.6-ml reaction tube that was filled with distilled water to make a final volume of 20 pl. The tubes were placed in a thermal cycler preheated to 96°C and subjected to 25 cycles with the following parameters: 96°C for 15 s, 52°C for 15 s, and 60°C for 4 min. The cycle sequencing products were extracted with 
(3).
A total of 11 of the 13 seropositive individuals were found among 472 healthy blood donors (2), and a further 2 subjects were found among 31 healthy laboratory workers. B. burgdorferi DNA was detectable in urine samples from 3 of these 13 healthy subjects with B. burgdorferi-specific serum antibodies (Table 1) . A 290-bp fragment was seen on agarose gel electrophoresis, and these amplification products were subsequently purified and subjected to Taq cycle sequencing. The sequences from a 240-bp stretch of the PCR products are shown in Fig. 1 . When compared with published sequences for this region of burgdorferi has been found also in the cerebrospinal fluid without concurrent inflammatory signs (16) .
